Skip to content

Analysis of the diagnostic efficacy of multi parameter breast ultrasound and its combination with tumor markers in breast benign and malignant lesions

Analysis of the diagnostic efficacy of multi parameter breast ultrasound and its combination with tumor markers in breast benign and malignant lesions

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032827
Enrollment
Unknown
Registered
2020-05-12
Start date
2020-05-11
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

with&#32
tumor&#32
Gold Standard:Pathological diagnosis
ultrasound&#32
combined&#32

Sponsors

The First Affiliated Hospital of Hebei North University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patients aged >= 18 years, female; 2. Conventional B-ultrasound showed that patients with BI-RADS grading of 4 and 5 were initially diagnosed; 3. Those patients who plan to perform core needle biopsy of breast masses under the guidance of ultrasound in our hospital, or those who have pathological diagnosis after surgical resection; 4. If the same patient has multiple lesions, only the most suspicious or largest lesions are included in the study; 5. Patients who agree to participate in the study and signed informed consent;

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women; 2. Patients who have received microwave ablation, radiofrequency ablation, radiotherapy, chemotherapy and puncture biopsy before examination; 3. Patients with other malignant tumors; 4. Patients who have participated in other clinical studies in or within 30 days; 5. Other situations that the researchers think are not suitable to participate in the study.

Design outcomes

Primary

MeasureTime frame
CEA;CA15-3;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactLi Chaoxi

The First Affiliated Hospital of Hebei North University

117077398@qq.com+86 13831381011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026